Stay updated on Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial

Sign up to get notified when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-08T09:44:04.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:04:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T22:08:22.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new drug information, specifically the addition of Tucatinib and Vinorelbine, while significant details about the ZW25 study have been removed, including its phases and eligibility criteria.
    Difference
    45%
    Check dated 2025-04-16T14:37:40.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:25:51.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to include information on Stomach Cancer while removing references to Ovarian Cancer. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    0.2%
    Check dated 2025-04-01T23:29:51.000Z thumbnail image

Stay in the know with updates to Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trial of ZW25 in Advanced HER2+ Cancers Clinical Trial page.